Gwendolyn Binder
About Gwendolyn Binder
Title and Role at Cabaletta Bio
Gwendolyn Binder serves as the President of Science & Technology at Cabaletta Bio. She joined Cabaletta Bio in February 2019. Her leadership is instrumental in overseeing the company's scientific endeavors and technological advancements.
Board Memberships and Advisory Roles
Gwendolyn Binder serves on the Board of Directors of Instil Bio, Inc. She is also a member of the Scientific Advisory Board for Immatics N.V., contributing her extensive expertise in biotechnology to these organizations.
Previous Leadership Roles in Biotechnology
Before joining Cabaletta Bio, Gwendolyn Binder held several key positions in the biotechnology sector. She was the Executive Vice President of Science and Technology at Cabaletta and previously served as the Chief Technology Officer of Adaptimmune Therapeutics plc. Binder played a crucial role in establishing the U.S. arm of Adaptimmune and leading its research team. She built early manufacturing, quality, and translational research teams and provided oversight for building a commercial scale cell therapy manufacturing facility at Adaptimmune.
Contributions to Cell Therapy and Research
Gwendolyn Binder has made significant contributions to the field of cell therapy and research. She was instrumental in supporting the development of the first clinical lentiviral vector used in humans for engineered T cell therapy for HIV during her tenure at VIRxSYS Corporation. She also progressed multiple Investigational New Drug submissions for novel engineered T cell therapies in HIV and oncology.
Academic Background and Publications
Gwendolyn Binder earned her Ph.D. in Cellular and Molecular Medicine from Johns Hopkins University, where she studied viral immunology and translational research. She has authored over 30 publications in top international journals such as Science and Nature Medicine, establishing her as a recognized leader in the biotechnology sector for the translational and clinical advancement of novel T cell therapies.